Edit |   |
---|---|
Antigenic Specificity | CD326, Human (Oportuzumab Monatox biosimilar) |
Clone | Oportuzumab Monatox |
Host Species | Recombinant |
Reactive Species | human |
Isotype | scFv kappa-heavy |
Format | scFv fragment |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD326 Recombinant Antibody (Oportuzumab Monatox). Oportuzumab monatox (proposed INN, trade name Vicineum) is an antineoplastic. Chemically, oportuzumab is a single chain variable fragment of a monoclonal antibody which binds to epithelial cell adhesion molecule (EpCAM, the tumor-associated calcium signal transducer 1). |
Immunogen | n/a |
Other Names | Anti-CD326 Recombinant Antibody, Research Grade Oportuzumab Monatox, Anti-Human CD326 Recombinant Antibody(Oportuzumab Monatox), VB4-845, Antibody Drug Analogues, Monoclonal Antibody, YR1637, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 945228-48-8 |
Catalog # | YR1637 |
Price | please inquire |
Order / More Info | CD326, Human (Oportuzumab Monatox biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |